Sarosh Rana to Risk Assessment
This is a "connection" page, showing publications Sarosh Rana has written about Risk Assessment.
Connection Strength
0.577
-
Angiogenic Biomarkers for Preeclampsia in Clinical Setting: A New Era. Hypertension. 2023 10; 80(10):2029-2032.
Score: 0.136
-
Angiogenic Biomarkers for Risk Stratification in Women with Preeclampsia. Clin Chem. 2022 06 01; 68(6):771-781.
Score: 0.124
-
Cost effectiveness of the sFlt1/PlGF ratio test as an adjunct to the current practice of evaluating suspected preeclampsia in the United States. Pregnancy Hypertens. 2021 Dec; 26:121-126.
Score: 0.119
-
Evaluation of angiogenic factors in the decision to admit women with suspected preeclampsia. Pregnancy Hypertens. 2020 Jul; 21:124-131.
Score: 0.108
-
Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia. Prenat Diagn. 2015 Apr; 35(4):386-93.
Score: 0.075
-
First trimester vitamin D, vitamin D binding protein, and subsequent preeclampsia. Hypertension. 2010 Oct; 56(4):758-63.
Score: 0.014